Walker Lab at MGH
@WalkerLabMGH
Research lab based in the Center for Genomic Medicine at Massachusetts General Hospital working to #EndNF.
You might like
From advancing treatments for cancer and cardiovascular issues to improving understanding of learning disabilities, NF studies make a difference far beyond the NF community. Donate today to #EndNF! secure.qgiv.com/for/curenfwith… #CureNFWithJack #WalkerLab #FundACure
We’re grateful for the support!
🌟 We’re so grateful to partner with Dr. Walker as he passionately researches NF! His dedication and determination inspire us all as we unite with a shared goal: to find a cure for NF. Together, we can make a difference! ✨ #CureNFwithJack #WalkerLab #EndNF #ResearchForACure
⛳️ Thank you to our amazing sponsors for making the 12th Annual CNFWJ Atlanta Golf Classic a huge success! 🎉 🏌️♂️ We’re grateful to have you by our side in making a difference! #CNFWJGolfClassic #ThankYouSponsors #GolfForACause
NTAP is #HIRING! Apply today to join the #NF team in this unique position, which involves seeing patients in the clinic and conducting research trials. Being a part of @HopkinsMedicine has benefits. Search for REQ 115943 or 115950 jobs.jhu.edu
Every penny that is raised through the 12th Annual Atlanta Golf Classic will support the MGH/Harvard Walker Lab dedicated solely to NF1 research. Donations will provide seed money to NF researchers and research-based NF entities for the most promising preclinical research.
Read more about this research in our ‘First person’ interview with Stephanie Bouley: journals.biologists.com/jcs/article/13…
This year, CNFWJ is proud to continue funding a postdoctoral research fellow at the Walker Lab. In previous years, we helped sponsor clinical trials that led to the first FDA-approved NF drug for reducing certain NF tumors. Every penny you donate brings us closer to #EndNF
Glad to see this work published and to have had a part in it!
Stephanie Bouley @SJB1120 and colleagues @MSBDartmouth @CGM_MGH identify BORC, a complex required for lysosome trafficking, as a promising therapeutic target for NF1-deficient tumors. Highlight: journals.biologists.com/jcs/article/13… Article: journals.biologists.com/jcs/article/13…
NTAP is #HIRING! If you are a recent grad or have Physician Asst. / Nurse Practitioner entry-level experience, apply to this position on our #NF team that sees patients in the clinic and trials. Physician Asst: bit.ly/3LIXfQZ Nurse Practitioner: bit.ly/4c3bZ7W
Looking forward to reconnecting with other NF researchers at the Global NF Conference this week in Brussels!
We are so thankful to be the recipients of this funding to help fuel our efforts to #EndNF!
HBI Connectome Spotlight: @Joanna22c "I lead the Brain, Education, and Mind (BEAM) Lab, conducting research on the brain and behavior links underlying reading development, difficulty, and intervention." @BEAMstudies @MGHInstitute brain.harvard.edu/hbi_connectome…
We're partnering with @WalkerLabMGH. They're using a combination of genetic, molecular and biochemical approaches to improve our understanding of NF1 and identify therapeutic targets. #EndNF #CureNF #CureNFwithJack
Srirupa Bhattacharyya, PhD of @MassGeneralNews presents Preclinical Evaluation of the Third-generation, Bi-steric mTORC1-selective Inhibitor RMC-6272 in NF2-deficient Models. #makenfvisible #endnf #MedEd #MedTwitter #MedX #NFYIF
Jack sent an email out today to many of his friends and supporters. He knew he did not have everyone's email address so he asked to post an update here too. #ENDNF #GreatJacksby curenfwithjack.com/2023/10/12/you…
Get your clubs ready for a weekend of cocktails and golfing! The greens await, and it's almost time to tee off! #RegisterToday #GreatJacksbyWeekend #CureNFwithJack #EndNF #CureNF
Congratulations to our collaborator Dr Richa Saxena on her new position!
Congratulations to Dr. Richa Saxena, our new vice chair of research & innovation! 🎊 Her work in sleep & circadian rhythm disorders is revolutionizing sleep-related care, outcomes & genomic medicine. Hear more about her 😴 research on the MGH podcast: spklr.io/6019lWUc
Celebrating a new academic year together and our four faculty members who were promoted @harvardmed this summer. Congratulations to our new Associate Professors, Justin Jordan and Michael Parsons, and Assistant Professors, Albert Kim and Vanessa Merker!
The deadline is TOMORROW! Have you submitted your abstract for #NFYIF23? Submit here: ce.ceconcepts.com/NFYIF23 @ChildrensTumor
info.ceconcepts.com
Neurofibromatosis Young Investigators' Forum
Neurofibromatosis Young Investigators' Forum
📢 Only 2 WEEKS LEFT! Share your #NF research at #NFYIF23 in Baltimore this Nov. Jr Faculty, Fellows, PhD Students & Postdocs. 🚨 Submit your abstract by Sept 7th. 🚨 Don't miss out on this opportunity! Submit Before Time Runs Out👉 ce.ceconcepts.com/NFYIF23 @ChildrensTumor
Laser-focused on safe treatment solutions and unmet medical needs for NF1 patients, today Healx announced they have been granted Orphan Drug Designation by the FDA for an AI-discovered NF1 treatment - a significant milestone for Healx + the NF1 community! businessweekly.co.uk/news/biomedtec…
United States Trends
- 1. Luka 59.6K posts
- 2. Lakers 45.9K posts
- 3. Clippers 17.3K posts
- 4. #DWTS 93.9K posts
- 5. #LakeShow 3,435 posts
- 6. Kris Dunn 2,455 posts
- 7. Robert 135K posts
- 8. Kawhi 6,037 posts
- 9. Reaves 11K posts
- 10. Jaxson Hayes 2,307 posts
- 11. Ty Lue 1,509 posts
- 12. Alix 15K posts
- 13. Elaine 46K posts
- 14. Collar 42.4K posts
- 15. Jordan 118K posts
- 16. Zubac 2,275 posts
- 17. Ezra 15.3K posts
- 18. NORMANI 6,170 posts
- 19. Dylan 35K posts
- 20. Colorado State 2,385 posts
Something went wrong.
Something went wrong.